Home > Balance Sheet > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Sundry Debtors

    Back to Balance Sheet
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Sundry Debtors History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Sundry Debtors ₹1,866 Cr₹1,844 Cr₹1,944 Cr₹1,632 Cr₹1,523 Cr

What is the latest Sundry Debtors ratio of TORRENT PHARMACEUTICALS ?

The latest Sundry Debtors ratio of TORRENT PHARMACEUTICALS is ₹1,866 Cr based on Mar2025 Consolidated results.
Year Sundry Debtors
Mar2025₹1,866 Cr
Mar2024₹1,844 Cr
Mar2023₹1,944 Cr
Mar2022₹1,632 Cr
Mar2021₹1,523 Cr

How is Sundry Debtors of TORRENT PHARMACEUTICALS Trending?

Years Sundry Debtors % Change
Mar2025 ₹1,866 Cr
1.20
Mar2024 ₹1,844 Cr
-5.12
Mar2023 ₹1,944 Cr
19.07
Mar2022 ₹1,632 Cr
7.16
Mar2021 ₹1,523 Cr -

Compare Sundry Debtors of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹121,150.6 Cr NA -0.9% 4.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,197.0 Cr 0.9% -0.2% -12.5% Stock Analytics
DIVIS LABORATORIES ₹159,634.0 Cr 0.1% 0.4% 16.6% Stock Analytics
CIPLA ₹126,082.0 Cr 0.5% 3.8% -3.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,783.0 Cr 2.8% 6.9% -2% Stock Analytics
MANKIND PHARMA ₹107,183.0 Cr 1.8% 6.6% 8.2% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS NA

-0.9%

4.9%

SENSEX

1%

2.1%

0.5%


You may also like the below Video Courses